Ticker Scorecard - APGE Basics Company: Apogee Therapeutics, Inc. IPO Date: July 14, 2023 Sector: Healthcare Industry: Biotech Market Cap: $1.97B Activated in VL: True Average Daily Range Avg Daily Range: $1.11 | 2.84% Avg Daily Range (30 D): $1.12 | 2.72% Avg Daily Range (90 D): $1.37 | 2.86% Institutional Daily Volume Avg Daily Volume: .36M Avg Daily Volume (30 D): .44M Avg Daily Volume (90 D): .39M Trade Size Avg Trade Size (Sh.): 57 Avg Trade Size (Sh.) (30 D): 50 Avg Trade Size (Sh.) (90 D): 49 Institutional Trades Total Inst.Trades: 711 Avg Inst. Trade: $2.78M Avg Inst. Trade (30 D): $2.29M Avg Inst. Trade (90 D): $2.64M Avg Inst. Trade Volume: .06M Avg Inst. Trades (Per Day): 2 Market Closing Trades Avg Closing Trade: $3.68M Avg Closing Trade (30 D): $2.94M Avg Closing Trade (90 D): $3.05M Avg Closing Volume: 81.48K     News Feb 3, 2025 @ 12:00 PM Apogee Therapeutics Announces First Patient Dosed ... Source: N/A Dec 2, 2024 @ 11:00 AM Apogee Therapeutics Highlights Progress and Best-i... Source: N/A Oct 16, 2024 @ 11:00 AM Apogee Therapeutics Announces Poster Presentation ... Source: N/A Aug 19, 2024 @ 11:00 AM Apogee Therapeutics Announces First Participants D... Source: N/A Jul 6, 2024 @ 4:19 AM Insider Sale: Carl Dambkowski Sells Shares of Apog... Source: Gurufocus Financials   TTM Q2 2024 Q1 2024 Basic EPS $-.86 $-.6 $-.64 Diluted EPS $-.86 $-.6 $-.64 Revenue $ M $ M $ M Gross Profit $ $ $ Net Income / Loss $ -49.02M $ -33.82M $ -32.09M Operating Income / Loss $ -58.69M $ -44.12M $ -38.18M Cost of Revenue $ $ $ Net Cash Flow $ -188.52M $ -178.16M $ 367.14M PE Ratio     Splits Jan 08, 2008:   50:1